Welcome to DrugBase!
Updated Warnings for Fluoroquinolone Antibiotics
Posted in: News Under: Drug Alerts On: July 27th, 2016
The FDA today approved an update to the safety labeling of the fluoroquinolones class of antibiotics, aiming to enhance warnings about their association with disabling and potentially permanent side effects and to thus limit their use in patients with less serious bacterial infections.
First Absorbable Stent for CAD Approved
Posted in: News Under: New Drugs On: July 25th, 2016
The FDA approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresectable Vascular Scaffold System (BVS), which releases the drug everolimus to limit the growth of scar tissue, is gradually absorbed by the body in approximately 3 years.
Xiidra (lifitegrast) Approved for Dry Eye Disease
Posted in: News Under: New Drugs On: July 21st, 2016
The FDA approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease. Xiidra is the first medication in a new class of drugs, called lymphocyte function-associated antigen (LFA-1) antagonist, approved by the FDA for dry eye disease.
Baby Drink to be Pulled Off the Market
Posted in: News Under: Drug Alerts On: July 21st, 2016
According to notice No. 73-2016 issued from the Central Administration of Pharmaceutical Affairs, the infant dietary supplement Baby Drink is to be pulled of the market due to its incompatibility with the age range it is presumably indicated for.